Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Therapeutics (CTIC) -- Ignore unavailable to you. Want to Upgrade?

To: Sam Citron who wrote (633)	3/17/2005 7:07:44 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 946

I am anything other than thrilled that it's cheap. I don't think about doubling down in this type of stock... just never occurs to me for anything other than big-science, heavy internal development places. That has cost me dearly in the past.... not trying to say that it's been a good habit.

To: Sam Citron who wrote (633)	3/17/2005 7:14:48 PM
From: IRWIN JAMES FRANKEL	Read Replies (1) \| Respond to of 946

I find pgs's cynicism refreshing and insightful. The inference to be drawn from insider buying is well known. It is also well known that multiple insider buys is even more positive. I am personally convinced that corporate sharpies use these inferences to skin the simple. If you could ever prove that the insider buying was orchestrated for the purpose of defrauding the investing public it would make a wonderful RICO case. None of these comments are intended to suggest wrongdoing on the part of CTIC insiders. I have no reason to think the theory applies to them. ij